Stephens Inc. AR Buys 265 Shares of HCA Healthcare, Inc. $HCA

Stephens Inc. AR boosted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 3.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 8,500 shares of the company’s stock after purchasing an additional 265 shares during the quarter. Stephens Inc. AR’s holdings in HCA Healthcare were worth $3,256,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently modified their holdings of the company. Park Place Capital Corp boosted its position in shares of HCA Healthcare by 2,336.0% during the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after acquiring an additional 1,168 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of HCA Healthcare by 11.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after acquiring an additional 2,698 shares during the last quarter. Harrell Investment Partners LLC boosted its position in shares of HCA Healthcare by 176.3% during the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after acquiring an additional 1,158 shares during the last quarter. Brown Advisory Inc. raised its holdings in shares of HCA Healthcare by 53.9% during the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock valued at $1,600,000 after buying an additional 1,622 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. raised its holdings in shares of HCA Healthcare by 2.5% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company’s stock valued at $1,491,000 after buying an additional 105 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on HCA. Bank of America raised their price objective on HCA Healthcare from $375.00 to $410.00 and gave the company a “neutral” rating in a report on Wednesday, September 10th. Robert W. Baird lifted their price target on HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Royal Bank Of Canada decreased their price target on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a research note on Monday, July 28th. Barclays lifted their price target on HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research note on Thursday, September 18th. Finally, Wells Fargo & Company boosted their target price on HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 7th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $437.19.

HCA Healthcare Trading Up 2.1%

NYSE:HCA opened at $441.08 on Thursday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $443.41. The stock has a 50-day moving average price of $412.90 and a 200 day moving average price of $380.12. The stock has a market capitalization of $103.21 billion, a P/E ratio of 18.54, a P/E/G ratio of 1.37 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same period in the prior year, the company earned $5.50 earnings per share. The firm’s revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were given a dividend of $0.72 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare’s payout ratio is 12.11%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.